SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Shrivastava, A
Right arrow Articles by Misra, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shrivastava, A
Right arrow Articles by Misra, R
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Anti-cardiolipin and anti-beta 2 glycoprotein Iantibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures

A Shrivastava

S Dwivedi

A Aggarwal

Department of Clinical Immunology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

R Misra

Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow-226 014, India

The aim of this study was to examine whether the clinical features of antiphospholipid antibody syndrome are associated with anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with SLE. Seventy-six patients (71 females), who fulfilled 1982 ACR criteria for SLE, were prospectively studied for the clinical features of antiphospholipid antibody syndrome (APS), and their sera were analysed for the presence of IgG/IgM/IgA anti-cardiolipin antibodies (aCL) by an in-house ELISA and, in 65 of them, for the presence of IgG anti-beta2 glycoprotein I antibodies (anti-beta2 GPI)by a commercial kit. Thirty-nine (51%) patients were positive for aCL, all of which were positive for IgG aCL, either alone (79.6%) or along with IgM and/or IgA. Twenty-seve(69.3%) out of 39 aCL-positive and seven (26.9%) out of 26 aCL-negative sera were positive for IgG antibodies to beta2 GPI. There was a significant corr elation (r = 0.66, P > 0.05) between the levels of aCL and anti-beta2 GPI antibodies. Forty-one patients had features of definite or suggestive APS. Thrombocytopenia, recurrent pregnancy loss and CNS manifestations (seizures eight, infarct one) were seen in 20, 13 and nine patients, respectively. Thrombosis of the peripheral vessels was seen in only one patient. Only the presence of seizures was significantly associated with the presence of aCL and anti-beta2 GPI antibodies (P > 0.05). The characteristic association of definite APS (recurrent pregnancy loss and arterial/venous thrombosis) was lacking.

Key Words: thrombosis • auto-antibodies • seizures

Lupus, Vol. 10, No. 1, 45-50 (2001)
DOI: 10.1191/096120301671577528


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
R M Andrade, G S Alarcon, L A Gonzalez, M Fernandez, M Apte, L M Vila, G McGwin Jr, J D Reveille, and for the LUMINA Study Group
Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)
Ann Rheum Dis, June 1, 2008; 67(6): 829 - 834.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R Cimaz, P L Meroni, and Y Shoenfeld
Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome)
Lupus, April 1, 2006; 15(4): 191 - 197.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
I Uthman and M Khamashta
Ethnic and geographical variation in antiphospholipid (Hughes) syndrome
Ann Rheum Dis, December 1, 2005; 64(12): 1671 - 1676.
[Abstract] [Full Text] [PDF]


Home page
CephalalgiaHome page
S Appenzeller and L. Costallat
Clinical Implications of Migraine in Systemic Lupus Erythematosus: Relation to Cumulative Organ Damage
Cephalalgia, December 1, 2004; 24(12): 1024 - 1030.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Appenzeller, F. Cendes, and L. T.L. Costallat
Epileptic seizures in systemic lupus erythematosus
Neurology, November 23, 2004; 63(10): 1808 - 1812.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
J T Merrill
Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus
Lupus, November 1, 2004; 13(11): 869 - 876.
[Abstract] [PDF]


Home page
LupusHome page
J Sastre-Garriga and X Montalban
APS and the brain
Lupus, December 1, 2003; 12(12): 877 - 882.
[Abstract] [PDF]



Advertisement